Linezolid resistance in a clinical isolate of Staphylococcus aureus

  title={Linezolid resistance in a clinical isolate of Staphylococcus aureus},
  author={S. Tsiodras and H. Gold and G. Sakoulas and G. Eliopoulos and M. Ferraro},
  journal={The Lancet},
  • S. Tsiodras, H. Gold, +2 authors M. Ferraro
  • Published 2001
  • Medicine
  • The Lancet
  • The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various gram-positive bacteria, including meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Although instances of linezolid resistance in VRE have been reported, resistance has not been encountered among clinical isolates of S aureus. We have characterised an MRSA isolate resistant to linezolid that was recovered from a patient treated with this… CONTINUE READING

    Topics from this paper.

    Antimicrobial resistance to linezolid.


    Publications referenced by this paper.